One of the ironies of investment in the health sector is that if people are healthy or they can find alternative treatment then that is bad for business.
That has certainly been the impact of the craze for Ozempic, the diabetes drug that is now touted as a miracle weight-loss cure for the Western
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
